SCHEMBL24735547

SCHEMBL24735547

CN(C)Cc1ccccccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 1.00
ALDH1A1 P00352 2/20 1.00
TAAR1 Q96RJ0 2/20 0.73
AOC3 Q16853 1/20 0.64
HRH3 Q9Y5N1 1/20 0.62
CARM1 Q86X55 1/20 0.54
PRMT6 Q96LA8 1/20 0.54
PRMT8 Q9NR22 1/20 0.54
CHRNB2 P17787 1/20 0.54
CHRNA4 P43681 1/20 0.54
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
LMNA P02545 2/20 0.52
CA12 O43570 2/20 0.52
CA9 Q16790 2/20 0.52
ADRA2B P18089 1/20 0.52
ADRA2C P18825 1/20 0.52
SLC6A2 P23975 1/20 0.52
HTR2A P28223 1/20 0.52
SLC6A4 P31645 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27766437 1.00 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL15900 1.00 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL5014268 1.00 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
Iodide SCHEMBL6672021 0.97 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Trimethylammonium SCHEMBL8195424 0.97 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Hydrochloric Acid SCHEMBL8743641 0.97 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Bromide SCHEMBL414532 0.97 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Hydrochloric Acid SCHEMBL6391891 0.97 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL7911439 0.97 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Ammonia Solution, Strong SCHEMBL25238492 0.97 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530210-B2 Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2022-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530210-B2 Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators GRIN2B, GRIN2A, GRIN2C TSHR 766/4885ALDH1A1 2477/4885TAAR1 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.